The costs at a glance
| Published price reference | $229/month Ongoing compounded semaglutide price; first month advertised at $147 |
|---|---|
| Medication | Patient-specific compounded semaglutide; separate tirzepatide and wellness products |
| Commitment | Introductory first month followed by recurring ongoing price; confirm cancellation cutoff and prescription finality |
| Important context | Semaglutide is $147 for the first month, then $229/month. Site says 49 states excluding California. Confirm supply period, full selected term and refund conditions; same-dose pricing language allows later price changes. |
The renewal figure is clearer than the promotion alone
Meli Health's semaglutide page puts a first-month price and a later monthly price together. That is useful because a reader can see immediately that the initial payment is not the continuing budget. I would compare the service using the renewal figure and then treat the first-month reduction as a separate benefit. The broader catalog includes other wellness treatments, but they should not distract from the specific weight-care plan. My assessment turns on whether the product, pharmacy, follow-up and billing period are as clear as the introductory-versus-ongoing distinction before a reader authorizes a recurring purchase or transfers an existing prescription.
Start the ongoing budget at $229, not $147
The semaglutide offer is advertised at $147 for the first month and $229 per month afterward. If those prices apply for twelve consecutive equal monthly periods, simple arithmetic would be $2,666 before any separate costs; that is an illustration, not a verified annual package. I would first ask whether month means a calendar month or a four-week supply and whether any longer commitment applies. The selected quantity, shipping and clinical services should be written into the quote. A reader comparing providers should line up ongoing costs for the same time period rather than compare Meli's first payment with another service's regular renewal price. For a closer comparison, see our introductory-price and renewal-cost guide and apply those distinctions to the specific offer you receive.
The California exclusion is a real eligibility distinction
Meli says its services are available in forty-nine U.S. states and explicitly excludes California. I would keep that limitation visible instead of describing the service simply as nationwide. Even in an included state, a clinician still has to determine whether treatment is appropriate and the pharmacy must be able to dispense the prescribed preparation. Someone moving or traveling should ask how their physical location affects follow-up and refills. An online intake is not a guarantee of a prescription. Before completing a transfer, confirm both clinical access and fulfillment for the actual state rather than rely on the broad geographic count.
Meli coordinates care rather than acting as every provider
The website describes Meli as a managed-services platform that supports medical consultations and prescription logistics. It says Meli does not itself prescribe or fill medication, and it names Rush Pharmacy for fulfillment. I would ask which licensed medical practice reviews the intake and how to contact that clinician separately from billing support. That distinction is helpful when a question concerns tolerability, a prescription change or the delivered preparation. The semaglutide page describes expedited shipping, but a courier promise does not include the time required for clinical review and pharmacy preparation. A practical refill schedule should account for each stage rather than assume immediate dispatch. For a closer comparison, see our telehealth appointment checklist and apply those distinctions to the specific offer you receive.
Compounded status should remain attached to the medicine
The semaglutide product page identifies a compounded preparation and says it is not the same as a brand-name product. I would ask the clinician why that specific option is being considered, what concentration the pharmacy will dispense and what instructions accompany it. Ingredient familiarity is not proof that a compounded product has the same approval or clinical evidence as a manufactured brand. This matters if a reader arrives after seeing a trial headline or a before-and-after advertisement. The relevant clinical discussion concerns the actual prescription and individual history, rather than borrowing every benefit attributed to semaglutide from studies of a different product or population. For a closer comparison, see our pharmacy verification guide and apply those distinctions to the specific offer you receive.
Same price by dose is not a permanent price guarantee
Meli's general disclosures qualify same-price-at-every-dose promotions by allowing later price changes due to supply or market conditions. Introductory offers also have their own limits. I would therefore separate two questions: does moving to a different prescribed dose change today's selected plan price, and can the company change its regular price later? Those are different risks. Ask how advance notice is provided, whether the current rate is protected for a purchased term and which price appears at the next renewal. A clear answer prevents an all-dose slogan from being mistaken for an unlimited lifetime rate lock or a promise about future pharmacy availability.
The support and refund routes need to be established upfront
Meli advertises continuing support and directs billing or cancellation questions to its support team. Its FAQ notes that refunds are limited once prescriptions or compounded medication have been dispensed. I would request the exact cancellation cutoff and ask whether pharmacy preparation ends refund eligibility before shipment. Also ask how a medical disqualification or treatment change is handled and whether any remaining prepaid portion is refundable. These details are especially important if checkout offers more than one month at a time. Keep a copy of the order and policy, and avoid treating a quick reply from administrative support as a substitute for clinical reassessment when a new concern arises.
My take: a straightforward renewal anchor, with local and policy checks
I would compare Meli for a reader outside California who wants a semaglutide offer with an explicitly stated introductory and ongoing rate. The useful number is $229 for continuing budgeting, with the first-month reduction considered separately. My remaining decision points would be the actual supply period, clinical practice, pharmacy instructions and refund cutoff. Wellorithm is useful to compare: compare another offer that distinguishes first-month and renewal pricing instead of extending an introductory rate into the ongoing budget. SkinnyRx offers a second reference: compare the full continuing cost and selected preparation behind a separate compounded-treatment introductory promotion.
Before you sign up
- Is $229 billed every calendar month or every four weeks?
- Which clinical practice handles my assessment and ongoing questions?
- What notice precedes any price change, and when is an order non-refundable?
Use the answers to compare the exact offer with another provider. A service review cannot determine whether a medication is appropriate for you; that decision belongs with your clinician.
Compare the complete budget · Save your provider checklist